Cohen Veterans Bioscience Receives Research Award from Department of Defense’s Medical Research and Materiel Command to Establish A Clinical Trial Infrastructure and Conduct an Adaptive Platform Trial Testing Post-Traumatic Stress Disorder (PTSD) Pharmacotherapeutics
October 4, 2018Read moreCohen Veterans Bioscience will establish a clinical trial infrastructure and serve as the Clinical Coordinating Center for a 3.5-year study to comparatively test pharmacotherapeutics for PTSD.
Cohen Veterans Care Summit – October 10-11, 2018
October 4, 2018Read moreThe third annual Cohen Veterans Care Summit will focus on effective Learning Mental Health Systems and the CVB-CVN model for continuous growth in the field of mental health treatment and research.
Cohen Veterans Bioscience Expands Digital Health Platform with Early Signal Expertise
September 6, 2018Read moreEarly Signal subsidiary will expand CVB’s role as a hub for translational research and data analytics to fast-track solutions for brain disorders
State of the Science Summit – September 12-13, 2018
July 24, 2018Read moreThe inaugural State of the Science Summit (SOSS) will focus on Diagnosis of Trauma-Related Brain Disorders and will be held in Silver Spring, Maryland on September 12-13, 2018.
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
June 7, 2018Read moreBrainsway, a leader in the advanced non-invasive treatment of brain disorders, and Cohen Veterans Bioscience today announced the launch of a new research collaboration with the Stanford University School of Medicine to identify potential biomarkers in patients suffering from Post Traumatic Stress Disorder (PTSD).
News
